The helix -loop -helix protein Id-1 has been suggested to play a positive role in cell proliferation and tumorigenesis of many types of human cancers. However, little is known about the molecular mechanism involved in the function of Id-1. In this study, using four stable Id-1 transfectant clones, we investigated the involvement of MAPK signaling pathway in the Id-1 induced serum independent prostate cancer cell growth. Our results demonstrated that both transient and stable ectopic Id-1 expression in prostate cancer LNCaP cells led to activation of the Raf/MEK1/2 signaling pathway. In addition, inhibition of MEK1/2 phosphorylation by one of its inhibitors, PD098059, resulted in the decreased cell cycle S phase fraction and cell growth rate, suggesting that activation of MAPK signaling pathway is essential for Id-1 induced prostate cancer cell proliferation. Furthermore, treatment with antisense oligonucleotide complementary to Id-1 mRNA in PC-3 and DU145 cells resulted in a decreased Id-1 expression which was accompanied by decreased Egr-1 protein. Our results suggest for the first time that the function of Id-1 is associated with MAPK signaling pathway activation and indicate a possible novel mechanism in which Id-1 regulates prostate cancer cell growth and tumorigenesis.
Id proteins (inhibitor of differentiation or DNA binding) are a group of helix -loop -helix (HLH) transcription factors that lack the DNA binding domain (Benezra et al., 1990) . These proteins act as dominant inhibitors of basic HLH transcription factors by hereodimerization (Ristow, 1996) . Increased expression of Id-1 protein has been reported in many types of human cancers including breast (Lin et al., 2000) , prostate (Ouyang et al., 2002a) , pancreas (Kleeff et al., 1998; Maruyama et al., 1999) and head and neck (Langlands et al., 2000) . Recently, expression of Id-1 has been suggested as a marker for unfavorable prognosis in cervical cancer (Schindl et al., 2001) and associated with advanced stages of prostate cancer (Ouyang et al., 2002a) . These results implicate that Id-1 may function as an oncogene. Previous studies suggest that one of the oncogenic functions of Id-1 may be through inactivation of p16 INK4a , leading to dysfunction of p16
INK4a /RB tumor suppressor pathway (Polsky et al., 2001; Ouyang et al., 2002b) . Recently, Id-1 has been shown to facilitate human primary fibroblasts escaping senescence through Ras-Raf-MEK signaling pathway (Ohtani et al., 2001) . In addition, one of the downstream effectors of the MAPK pathway, Egr-1 (early growth response-1), has been reported to interact with Id-1 (Tournay and Benezra, 1996) . These results suggest that the oncogenic effect of Id-1 may be multifunctional and regulated through different pathways. Recently, we reported an upregulation of Id-1 during sex hormone induced prostate carcinogenesis in a Noble rat model (Ouyang et al., 2001 ) and increased Id-1 expression was also correlated with the Gleason grading of human prostate cancer (Ouyang et al., 2002a) . Since the activation of MAPK pathway and overexpression of one of its downstream effectors, Egr-1, are found to be associated with advanced human prostate cancer (Eid et al., 1998; Gioeli et al., 1999) , in this study, we investigated whether MAPK pathway contributed to the Id-1 induced prostate cancer cell proliferation observed in our previous studies (Ouyang et al., 2002b) .
Previously, we found that expression of Id-1 was undetectable in serum free culture conditions in LNCaP cells and generated stable transfectants expressing different levels of Id-1 in the absence of serum. We reported that ectopic Id-1 expression was able to stimulate serum independent cell proliferation through inactivation of p16
INK4a /RB pathway (Ouyang et al., 2002b) . In the present study, using four stable Id-1 transfectant clones (C1 to C4), we investigated the possible contribution of MAPK pathway in Id-1 induced serum independent cell proliferation observed Figure 1 Effect of ectopic Id-1 expression on Raf-1, MEK1/2 and Egr-1 expression in LNCaP cells. Stable Id-1 transfectants and the vector control pBabe were generated as previously described (Ouyang et al., 2002b) . Cells were cultured in serum free RPMI 1640 medium for 48 h. (a) and (c) Western blotting analysis of Id-1, Raf-1, MEK1/2 and Egr-1 expression in Id-1 transfectants and the controls pBabe and LNCaP cells. Cell lysates were prepared by resuspending cell pellets in lysis buffer (20 mM Tris HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 1 mg/ml leupeptin, 1 mg/ml aprotinin, 1 mM PMSF). Protein concentration was assayed using D C Protein Assay kit (Bio-Rad, Hercules, CA, USA). Equal amount of protein (30 mg) was loaded onto a SDS-polyacrylamide gel for electrophoresis and then transferred on a PVDF membrane (Amersham, Piscataway, NJ, USA). The membrane was then incubated with primary anti-(Continued overleaf) in LNCaP cells. As shown in Figure 1a , in the absence of serum for 48 h, there was no detectable levels of Id-1 expression in the control pBabe and LNCaP cells, while Id-1 protein expression was evident in the Id-1 transfectants. In addition, there was an increase in the expression of phosphorylated form of Raf-1 (Ser259) and MEK1/2 (Ser217/221) proteins in all of the Id-1 transfectant clones. However, the phosphorylated Raf-1 and MEK1/2 was much lower in the controls cultured in the same conditions. In addition, the increased levels of phosphorylated Raf-1 and MEK1/ 2 proteins appeared to be correlated with the levels of Id-1 expression. In contrast, Western blotting using antibodies recognizing the total levels of each protein (non-phosphorylated and phosphorylated forms) showed no difference between the controls and the Id-1 expressing clones. Since activation of Raf-1 and MEK signaling is through phosphorylation (Fan et al., 2000) , these results indicate that exogenous Id-1 expression in LNCaP cells resulted in a direct activation of Raf/MEK1/2 kinases. The expression of Egr-1, one of the downstream effectors of the Raf/ MEK1/2 pathway, was also shown to be increased at both transcriptional ( Figure 1b ) and protein levels ( Figure 1c ). It has been reported that activation of Egr-1 expression by Erk MAPK pathway leads to transcriptional activation of another Id family member, Id-3, in mouse thymocytes (Bain et al., 2001) . To investigate if the increased Egr-1 expression by Id-1 in LNCaP cells could effect the transcription and protein expression of Id-3, we performed RT -PCR and Western blotting analysis. As shown in Figure 1d ,e, we did not observe any significant changes in Id-3 mRNA and protein levels between the Id-1 transfectants and the controls. These results suggest that unlike observed in mouse cells, activation of Egr-1 in LNCaP cells did not result in transcriptional activation of the Id-3 gene. It is possible the Egr-1 induced Id-3 activation observed previously (Bain et al., 2001 ) may be a specific effect in mouse thymocytes.
It is possible that the effect of Id-1 expression on MEK1/2 phosphorylation and Egr-1 induction may be due to clonal variation during generation of the stable Id-1 transfectants, therefore, we repeated the Id-1 overexpression experiments and generated transient transfectants. Forty-eight hours after transfection, cells transfected with pBabe and pBabe-Id-1 vectors were cultured in serum free medium for another 48 h and then tested for the expression of Id-1, MEK1/2 and Egr-1. As shown in Figure 2 , Id-1 protein was detected in the cells transfected with pBabe-Id-1 but not in the vector control and the parental cells. In addition, the increased Id-1 expression was associated with increased MEK1/2 phosphorylation and the level of Egr-1 protein expression (up to threefold), while total level of the MEK1/2 protein remained unchanged. These results are consistent with the evidence from the stable transfectants and suggest that ectopic Id-1 expression in LNCaP cells leads to activation of Raf/MEK1/2 signaling pathway.
In order to study whether activation of MAPK signaling pathway played a role in Id-1 induced serum independent cell proliferation in LNCaP cells, all the Id-1 expressing clones and the controls were treated with PD098059, a selective inhibitor of MEK1/2 (Dudley et al., 1995) . As shown in Figure 3a , decreased levels of phosphorylated MEK1/2 protein were observed with increased concentrations of PD098059 (25, 50 and 75 mM) in all of the Id-1 expressing clones while it was undetectable in the control pBabe and the parental LNCaP cells. In contrast, the basal levels of MEK1/2 protein (non-phosphorylated and phosphorylated forms) remained unchanged under the same culture conditions in all of the cell lines. This indicates that treatment with PD098059 in Id-1 expressing LNCaP cells inhibited phosphorylation of MEK1/2. When the PD098059 treated cells were studied for Egr-1 expression, both mRNA and protein levels were also decreased with increased concentrations of PD098059 in all of the Id-1 expressing clones, but the effect was not so evident in the control pBabe and LNCaP cells bodies for 1 h at room temperature against phospho-Raf-1 (Ser259), phospho-MEK-1/2 (Ser217/221) and MEK-1/2 (Cell Signaling Technology, MA, USA), Id-1, Raf-1, Egr-1 and beta-actin (Santa Cruz Biotechnology, CA, USA). After washing with TBS-T, the membrane was incubated with secondary antibody against rabbit IgG and the signals were visualized by ECL Western blotting system (Amersham, NJ, USA). Note that ectopic Id-1 expression in C1 to C4 clones results in an increased phosphorylation of Raf-1 and MEK1/2, and expression levels of Egr-1. (b) RT -PCR analysis of Egr-1 mRNA expression. Total RNA was isolated using Trizol reagent according to the manufacturer's protocol (Invitrogen, CA, USA). The cDNA was synthesized using the SuperScript TM First Strand Synthesis System (Invitrogen, Carlsbad, CA, USA). The cDNAs were then amplified by PCR with Egr-1 specific primers (upstream: 5'-TGA CCG CAG AGT CTT TTC CT-3', downstream: 5'-TGG GTT GGT CAT GCT CAC TA-3') (Kawashita et al., 1999) . The PCR conditions were as follows: an initial denaturation at 958C was followed by 30 cycles of PCR (948C for 1 min, 558C for 1 min and 728C for 2 min), and a final extension at 728C for 5 min. The cDNA of b-actin was amplified as an internal control (primer details: sense: 5'-GTC GGG CGC CCC AGG CAC CA-3', antisense: 5'-CTC CTT AAT GTC ACG CAC GAT TTC-3') (Ling et al., 2001) . The PCR products were electrophoresed on a 2% agarose gel and analysed using a gel documentation system. Note that increased Egr-1 mRNA expression is shown in all of the Id-1 expressing clones. (d) RT -PCR analysis of Id-3 mRNA expression in LNCaP and its transfectants. cDNA was synthesized as described in the legend of (b) and amplified using specific primers (upstream: 5'-ACTCACTCCCCAGCATGAAG-3', downstream: 5'-AAGCTCCTTTTG-TCGTTGGA-3') (Sakurai et al., 2001) . The expression of b-actin was used as an internal control. The thermocycle program for the PCR reaction consisted of 35 cycles with 30 s at 948C, 30 s at 608C and 60 s at 728C, followed by one cycle for 7 min at 728C. (e) Id-3 protein expression in LNCaP and its transfectants by Western blotting analysis using an antibody against Id-3 (Santa Cruz Biotechnology). The expression of b-actin was examined as an internal control. Note that there is no significant difference in Id-3 mRNA and protein expression levels between Id-1 transfectants and the controls. Relative expression levels in RT -PCR and Western blotting experiments were determined by densitometric analysis and compared to LNCaP which was assigned the value of one. All results represent three independent experiments and the error bars indicate standard error of the means Id-1 stimulates prostate cancer cell proliferation M-T Ling et al (Figure 3b,c) . These results indicate that inhibition of MEK1/2 phosphorylation by PD098059 leads to inactivation of MEK1/2 kinase, thus resulting in a decreased MAPK signaling transduction activity.
To investigate if inhibition of MAPK pathway would effect the Id-1 induced cell proliferation in LNCaP cells, we studied cell cycle distribution and cell growth rate after exposure to PD098059 and compared to the untreated cells. As shown in Figure 4a , in the absence of PD098059, the control pBabe and LNCaP cells showed small percentage of S phase cells (1 -2%) but the increased percentage of S phase cells was observed in the Id-1 expressing clones (8 -13%) as previously reported (Ouyang et al., 2002b) . However, (Lin et al., 2000) were transfected into LNCaP cells respectively as described (Ouyang et al., 2002b) . Forty-eight hours after transfection, the cells were cultured in serum free medium for a further 48 h and cell pellets were collected. The expression of Id-1, MEK1/2 (both phosphorylated and total levels) and Egr-1 were examined by Western blotting as described in the legend of Figure 1 . Note that transient expression of Id-1 in LNCaP cells leads to increased MEK1/2 phosphorylation and activation of Egr-1 expression 5 cells were plated in culture medium containing 5% fetal calf serum. Twenty-four hours later, the culture medium was replaced by serum free medium for 48 h and then PD098059 or DMSO (solvent control) was added. Twenty-four hours later, the cells were harvested by trypsinization and then fixed with ice cold 70% ethanol for at least 1 h. Before testing, the fixed cells were washed with PBS and treated with RNase (1 mg/ml) and stained with propidium iodide (50 mg/ml) for 30 min at 378C. Flow cytometric analysis was performed on an EPICS profile analyser and analysed using the ModFit LT2.0 software (Coulter, Miami, FL, USA). Note that decreased percentage of S phase cells is shown in the Id-1 transfectants after exposure to PD098059. (b) Effect of PD098059 (75 mM) on Id-1 induced prostate cancer cell growth. Cells were plated at 150 000 per 10 cm 2 density in 12-well plates. The culture medium was changed to FCS free medium for 48 h and then PD098059 (75 mM) or DMSO (solvent control) was added. The cells were then trypsinized and viable cells were counted every 24 h using the Trypan blue assay. Each data point was derived from triplicate wells and each experiment was repeated at least three times. The error bars indicate the standard error of the means. Note that treatment with PD098059 in the Id-1 transfectants results in decreased cell growth when the cells were treated with PD098059 (25, 50 mM) for 24 h, the percentage of S phase cells in Id-1 expressing clones was decreased to the levels similar to the controls (1.5 -5%) (50 mM PD098059). The results on cell growth were also correlated with the cell cycle studies. In the absence of PD098059, the Id-1 expressing clones showed an increased growth rate compared to the controls (Figure 4b ). However, after treatment with PD098059, the growth rate of the Id-1 expressing cells was decreased with increased concentrations of PD098059 (data not shown). The highest concentration of PD098059 (75 mM) resulted in the growth reduction to the levels similar to the controls (Figure 4b ). These results indicate that inhibition of Raf/MAPK signaling pathway leads to the inhibition of Id-1 induced cell proliferation in LNCaP cells.
In order to further confirm the association between Id-1 and MAPK signaling pathway, we treated PC-3 and DU145 cell lines which showed relatively high levels of Id-1 expression, with antisense oligonucleotides complementary to Id-1 mRNA and a control oligomer (Hara et al., 1994) . We found that while the control oligomer treated cells did not show any changes in the expression levels of Id-1, phosphorylated MEK1/2 and Egr-1 proteins compared to the untreated control, the Id-1 antisense oligonucleotide treatment in these cells not only decreased the expression of Id-1 protein but also the expression of the MAPK downstream effector, Egr-1 (Figure 5 ). The decreased Id-1 and Egr-1 expression was also associated with decreased cell proliferation rate (data not shown). These results further support the hypothesis that MAPK signaling pathway activation is essential for Id-1 induced serum independent cell growth in prostate cancer cells.
Initially identified as gene products whose function is the negative control of cell differentiation, the Id proteins have been reported to play roles from cell proliferation, cell cycle progression, cellular senescence to cell migration and angiogenesis Benezra et al., 2001 ). This indicates that the oncogenic function of Id proteins is regulated through multiple molecular pathways. Id-1, in particular, has been shown to be necessary in overcoming replicative senescence (Alani et al., 1999; Nickoloff et al., 2000) , cell cycle G 1 to S progression (Hara et al., 1994; Peverali et al., 1994; Ouyang et al., 2002b) and cancer cell migration (Lin et al., 2000) . Although increasing evidence suggests that Id-1 is an essential proliferative factor in a number of cell types (Alani et al., 1999; Nickoloff et al., 2000; Lin et al., 2000; Ouyang et al., 2002b) , little is known about the molecular mechanism involved in its function. It has been reported that Id proteins dimerize with and inhibit the E2A HLH transcription factors which play important roles in regulation of cell differentiation and suppression of cell growth (Peverali et al., 1994) . Overexpression of Id-1 can overcome the growth-inhibitory effect of E2A leading to initiation of cell proliferation (Olson and Klein, 1994) and the entry from G 1 to S phase of the cell cycle (Peverali et al., 1994) . These results indicate that the balance between E2A and Id-1 is critical in regulating cell proliferation. Recently, several studies have also suggested that Id-1 may regulate cell proliferation through inactivation of p16
INK4a /RB pathway (Ouyang et al., 2002b; Ohtani et al., 2001; Alani et al., 2001) . In this study, after ectopic expression of Id-1 protein in LNCaP cells, we found increased Raf-1 and MEK1/2 phosphorylation and transcription activation of one of their downstream effectors, Egr-1, (Figures 1 and 2 ). This indicates that ectopic Id-1 expression in these cells resulted in activation of Raf/MEK1/2 signaling pathway. Inhibition of MEK1/2 by its specific inhibitor, PD098059, led to the downregulation of MEK1/2 phosphorylation (Figure 3) , which was accompanied by decreased Egr-1 expression, cell cycle S phase fraction and cell growth rate (Figures 3 and 4) in LNCaP cells. These results strongly suggest that activation of Raf/MEK1/2 signaling pathway is essential for Id-1 induced serum independent prostate cancer cell proliferation. Although Id-1 has been linked to Ras-Raf-MAPK Figure 5 Reduction of Id-1 and Egr-1 protein expression by antisense oligomers complementary to Id-1 mRNA in PC-3 and DU145 cells. Phosphorothiolated antisense oligonucleotide complementary to Id-1 mRNA and control oligomer were synthesized by Invitrogen (Carlsbad, CA, USA) according to the sequences described previously (Hara et al., 1994) . Cells were cultured in serum free medium for 48 h and control oligomer (20 mM) or Id-1 antisense oligonucleotide (10 or 20 mM) was added for 48 h. Western blotting analysis was performed as described in the legend of Figure 1 . Note that inactivation of Id-1 by antisense oligonucleotides leads to decreased Egr-1 expression in both cell lines pathway in human fibroblasts (Ohtani et al., 2001) , our study is the first report implicating a connection between MAPK signaling pathway and Id-1 induced cell proliferation in human cancer cells.
In prostate cancer, the levels of the activated MAPK kinases and the expression of Egr-1 mRNA increase with Gleason score and tumor stage (Eid et al., 1998; Gioeli et al., 1999) , indicating that activation of MAPK signaling pathway plays important roles in prostate cancer progression and cancer cell growth. Recently, we have reported that Id-1 is upregulated during sex hormone-induced prostate carcinogenesis (Ouyang et al., 2001 ) and the levels of Id-1 expression are correlated with Gleason score in human prostate cancer (Ouyang et al., 2002a) . In this study, our results suggest a mechanic link between Id-1 and MAPK pathway in prostate cancer cell growth. It is possible that increased Id-1 expression may serve as a positive upstream regulator of MAPK signaling pathway in prostate cancer cells. Previously we have shown that the levels of Id-1 increase with prostate cancer progression from low grade to high grade tumors in a sex hormone-induced prostate cancer Noble rat model (Ouyang et al., 2001) , it is possible that the increased Id-1 expression may in turn activate MAPK signaling pathway therefore facilitating prostate cancer cell proliferation and prostate cancer progression. The evidence on the activation of MAPK signaling by overexpression of Id-1 in the present study also supports this hypothesis. In addition, the increased expression of Id-1 in combination with phosphorylated MAPK and high levels of Egr-1 may provide possible prognostic markers for prostate cancer proliferation and progression. Using the same cell line, we previously reported that the Id-1 induced prostate cancer cell proliferation was associated with the inactivation p16
INK4a /RB pathway (Ouyang et al., 2002b) . The evidence from the present study and previous studies strongly support the notion that the oncogenic function of Id-1 is regulated through multiple pathways.
In this study, we report for the first time that activation of MAPK signaling pathway plays an essential role in Id-1 induced prostate cancer cell proliferation. Since overexpression of Id-1, activation of MAPK and up-regulation of Egr-1 are correlated with prostate cancer growth and progression (Eid et al., 1998; Gioeli et al., 1999; Ouyang et al., 2002a) , our results showed a direct functional evidence on the relationship between Id-1 and MAPK signaling pathway in prostate cancer cells. Our evidence suggests a possible novel pathway in which Id-1 regulates prostate cancer cell growth and prostate tumorigenesis.
